Abstract
Elevated cerebrospinal fluid (CSF) levels of markers of oxidative stress, neuronal injury, and inflammation and decreased neurotransmitter levels have been reported in HIV-associated neurocognitive disorders (HAND). Minocycline may have a neuroprotective effect by inhibiting inducible nitric oxide synthase, which produces nitric oxide, a compound that induces oxygen free radical production. In A5235, “Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment,” minocycline was not associated with cognitive improvement, but the effect on the above CSF measures was not examined previously. The objective of this study was to examine the effect of minocycline on markers of oxidative stress, neuronal injury, neurotransmitter levels, and inflammation from CSF in participants in A5235. One hundred seven HIV+ individuals received either minocycline 100 mg or placebo orally every 12 h for 24 weeks. Twenty-one HIV+ individuals received the optional lumbar punctures. Lipid and protein markers of oxidative stress (e.g., ceramides and protein carbonyls), glutamate, neurotransmitter precursors, kynurenine metabolites, neurofilament heavy chain, and inflammatory cytokines were measured in the CSF before and after treatment. The 24-week change in ceramides was larger in a beneficial direction in the minocycline group compared to the placebo group. The two groups did not differ in the 24-week changes for other markers.
These results suggest that minocycline may decrease lipid markers of oxidative stress (ceramides) in individuals with HAND; however, an effect of minocycline on other CSF markers was not observed. A larger sample size is needed to further validate these results.
Similar content being viewed by others
References
Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 93:14014–14019
Bandaru VV, McArthur JC, Sacktor N, Cutler RG, Knapp EL, Mattson MP, Haughey NJ (2007) Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 68:1481–1487
Brown A, Islam T, Adams R, Nerle S, Kamara M, Eger C, Marder K, Cohen B, Schifitto G, McArthur JC, Sacktor N, Pardo CA (2011) Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. J Neurovirol 17:382–392
Burdo TH, Ellis RJ, Fox HS (2008) Osteopontin is increased in HIV-associated dementia. J Infect Dis 198:715–722
Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, Troncoso JC, Mattson MP (2004) Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer′s disease. Proc Natl Acad Sci U S A 101:2070–2075
Eckstein J, Ammerman GRJ, and B.L. Ackermann (2013) Simultaneous profiling of multiple neurochemical pathways from a single cerebrospinal fluid sample using GC/MS/MS with electron. pp 782–790
Epstein LG, Gendelman HE (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33:429–436
Giovannoni G, Nath A (2011) After the storm: neurofilament levels as a surrogate endpoint for neuroaxonal damage. Neurology 76:1200–1201
Graham NMH, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR, Phair JP (1992) The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 326:1037–1042
Haughey NJ, Cutler RG, Tamara A, McArthur JC, Vargas DL, Pardo CA, Turchan J, Nath A, Mattson MP (2004) Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol 55:257–267
Haughey NJ (2014) Astrocyte derived exosomes regulate the peripheral immune response to CNS inflammation. Presidential symposium on Exosomes and Neuroimmune Interactions. 20th Annual Society for Neuroimmune Pharmacology. (personal communication)
Kuhle J, Regeniter A, Leppert D, Mehling M, Kappos L, Lindberg RL, Petzold A (2010) A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein. J Neuroimmunol 220:114–119
Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B (2011) Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 17:63–69
Letendre SL, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65(1):65–70
McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67:699–714
Mielke MM, Bandaru VV, Haughey NJ, Rabins PV, Lyketsos CG, Carlson MC (2010) Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging 31:17–24
Nath A, Li W, Haughey N, McArthur JC, Sacktor N (2006) Oxidative and nitrosative stress markers in CSF correlate with active HIV dementia. Neurology 66:145
Notarangelo FM, Wu HQ, Macherone A, Graham DR, Schwarcz R (2012) Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain. Anal Biochem 421:573–581
Pardo CA, Buckley A, Thurm A, Lee LC, Azhagiri A, Neville DM, Swedo SE (2013) A pilot open-label trial of minocycline in patients with autism and regressive features. J Neurodev Disord 5:9
Sacktor N, Miyahara S, Deng L, Evans S, Schifitto G, Cohen BA, Paul R, Robertson K, Jarocki B, Scarsi K, Coombs RW, Zink MC, Nath A, Smith E, Ellis RJ, Singer E, Weihe J, McCarthy S, Hosey L, Clifford DB (2011) Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial. Neurology Sep 77:1135–1142
Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319(5267):1244–1247
Yadav A, Collman RG (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J NeuroImmune Pharm 4:430–447
Acknowledgments
The authors would like to thank Marie Sonderman for administrative support. The statistical analysis was carried out by S. Miyahara. This study was supported in part by the AIDS Clinical Trials Group (ACTG) funded by the following: NIAID, AI38858, AI38855, AI27670, AI27668, AI27658, AI34853, AI127660, AI27664, AI27659, AI25903, AI25915, AI046376, AI46370, AI46381, AI50410, AI25868, AI46386, CFAR AI 127757, the Neurologic AIDS Research Consortium, NS32228, NS081196, NS055628, MH075673, MH64409, AI 068634 and GCRC Units funded by the National Center for Research Resources (NCRR), RR00052, RR00044, RR00046. The NCT number for this study is NCT 00361257. This study is registered in Clinical Trials.gov. Participating site ACTG Clinical Trials Unit (CTU) grant numbers include the following:
University of California, San Diego Antiviral Research CTU Grant AI069432; Johns Hopkins University CTU Grant AI069465; CTSA Grant UL1 RR025005; UCLA School of Medicine CTU Grant AI069424; Washington University (St. Louis) CTU Grant AI069495; The Research & Education Group-Portland CRS CTU Grant AI069503; Henry Ford Hospital CRS CTU Grant AI069503; Massachusetts General Hospital CTU Grant AI069472; NYU/NYC HHC at Bellevue CTU Grant AI069532; Univ. of Colorado Hospital CTU Grant AI069450; Northwestern University CTU Grant AI069471; Virginia Commonwealth University Medical Center CRS CTU Grant AI069503; University of Washington (Seattle) CTU Grant AI069434; University of North Carolina CTU Grant AI069423; University of Rochester Medical Center CTU Grant AI069511; Emory University, The Ponce de Leon Center CTU Grant AI069452; and University of Pennsylvania, Philadelphia CTU Grant AI069467-04.
The project described was supported by Award Number AI068636 from the National Institute of Allergy and Infectious Diseases, National Institute of Mental Health (NIMH), and National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Sacktor, N., Miyahara, S., Evans, S. et al. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. J. Neurovirol. 20, 620–626 (2014). https://doi.org/10.1007/s13365-014-0292-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-014-0292-0